IS SURGERY AN OPTION FOR PATIENTS LIVING WITH STAGE 4 LUNG CANCER?
The Young Lung Cancer Initiative and EGFR Resisters host an informative webinar with MD Anderson’s thoracic oncologist, Dr. Carl Gay, and thoracic surgeon, Dr. Mara Antonoff. Dr. Gay and Dr. Antonoff present information on the potential role of surgery in metastatic oncogene-driven non-small cell lung cancer. Oncogenes include EGFR, ALK, ROS1, RET, EXON 20, HER2.
